Navigation Links
Arpida Enrols First Patients in "Intravenous-to-Oral" Switch Trial With Oral Iclaprim
Date:5/26/2008

REINACH, Switzerland, May 26 /PRNewswire-FirstCall/ -- Arpida Ltd (SWX: ARPN) today announced the enrolment of the first patients into the Phase II "intravenous-to-oral" switch trial with oral iclaprim in complicated Skin and Skin Structure Infections (cSSSI). Enrolment remains on track for completion in 2008.

The key objective of the study is to assess the clinical efficacy of an oral capsule formulation of iclaprim as step-down therapy in comparison with a full course of intravenous (i.v.) treatment with vancomycin in the treatment of cSSSI. The primary endpoint will be the clinical cure rate at the Test-of-Cure (TOC) visit. Secondary objectives include bacteriological outcomes as well as safety and tolerability.

This Phase II trial is designed as a multi-centre, double-blind, double-dummy comparative study. Patients suffering from cSSSI receive i.v. vancomycin for the first two days of treatment and are then randomised to either continue to receive i.v. vancomycin or to be switched to oral iclaprim for eight additional days. A total of 60 patients will be randomised for this study.

Dr Paul Hadvary, Head of Development of Arpida Ltd., commented: "Among the hospital anti-MRSA drugs that are currently in filing or late-stage development, only iclaprim shows oral bioavailability allowing clinical development and consequently offers the potential for intravenous-to-oral switch therapy. We consider the oral switch therapy to be an important option addressing an increasing therapeutic need. It allows patients to be sent home earlier, thereby increasing patient comfort, reducing the risk of contracting additional infections and lowering costs for the healthcare system. We feel the oral switch therapy could add significant potential to the intravenous formulation."

About Arpida Ltd.

Arpida (SWX: ARPN) is a biopharmaceutical company with research facilities in Reinach, Switzerland and in the USA. It focuses on the discovery and dev
'/>"/>

SOURCE Arpida Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Arpida Invited to Present Data on Iclaprim at Scientific Conference
2. Arpida Provides Further Comments on the Pivotal Phase III Trials
3. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
4. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
5. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
6. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
7. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Tainted Chinese Food Ingredients First Discovered in 2005
10. First Patient Enrolled in Europe in Ovature Phase III Ovarian Cancer Trial
11. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... MENLO PARK, Calif. , July 24, 2014 /PRNewswire/ ... company") announced today that the company,s board of directors approved ... to June 30. Accordingly, DelMar will file a Transition Form ... Jeffrey Bacha , president and CEO of DelMar stated, "The ... achieving our goal of obtaining a senior exchange listing for ...
(Date:7/24/2014)... Sciences, Inc. (NASDAQ: ALIM ) ("Alimera"), a ... commercialization of prescription ophthalmic pharmaceuticals, today announced that it ... financial results after the market close on Thursday, August ... the same day at 4:30 p.m. ET. ... Dan Myers , President and Chief Executive Officer, and ...
(Date:7/24/2014)... , July 24, 2014  Perrigo Company (NYSE: ... received an AB therapeutic equivalent rating from the U.S. ... New Drug Application (NDA) for testosterone gel 1.0%. FDA ... [AbbVie,s] AndroGel 1% and can be substituted with the ... effect and safety profile as AndroGel 1% when used ...
Breaking Medicine Technology:DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 2DelMar Pharmaceuticals Announces Change of Fiscal Year End and Provides Update on Glioblastoma Clinical Trial 3Alimera Sciences To Release Second Quarter 2014 Results 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3
... N.J. , July 12 Timothy G. Hayes , currently ... North America , will also lead the business unit,s Global Business Development ... , , ... the United States , Canada and Puerto Rico , ...
... July 13 A new free, white paper that guides ... Food and Drug Administration (FDA) regulations to combination products embedded with ... http://www.microtestlabs.com/combination-products-20/ ) , , ... Combination products are a large and growing segment of the medical ...
Cached Medicine Technology:Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care 2Timothy G. Hayes Appointed Head of Global Business Development for Bayer HealthCare Consumer Care 3New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 2New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 3New White Paper Helps Medical Device Manufacturers Apply New FDA Regs to Combination Products 4
(Date:7/25/2014)... By Steven Reinberg ... -- An "unacceptably low" number of girls and boys are ... anal and other cancers, U.S. health officials said Thursday. ... boys and girls aged 11 and 12 get the three-dose ... sexually active. Yet, despite a slight ...
(Date:7/25/2014)... Home Care Assistance – Halton/Peel Region ... in-home senior care, is weighing in on the recent ... projects in Alberta through their New Horizons for Seniors ... is a federal grants and contributions program that supports ... difference in the lives of others and in their ...
(Date:7/25/2014)... Stwd.co.uk, one of the leading dress manufacturers and ... evening dress for women. In addition, the reliable ... these items. They are available at discounted rates, up ... 30. , “We are pleased to announce our new ... a large number of stylish special occasion gowns for ...
(Date:7/25/2014)... 25, 2014 Ticket Down is ... Champions Cup Match between Manchester City and Liverpool FC ... of the most iconic locations is Yankee Stadium. It may ... it is quickly becoming a location that any major event ... to the New York Yankees from Major League Baseball, and ...
(Date:7/25/2014)... July 25, 2014 Mahendra Trivedi and ... Online Workshop ‘Consciousness is Power’ on Saturday, July 26, ... to attend this life transforming event as they will ... higher level. Few days are left for the commencement ... Trivedi and Trivedi Masters™ Dahryn Trivedi (his wife) and ...
Breaking Medicine News(10 mins):Health News:Too Few Teens Receive HPV Shot, CDC Says 2Health News:Too Few Teens Receive HPV Shot, CDC Says 3Health News:Home Care Assistance – Halton/Peel Region Weighs in on Alberta Communities Receiving Funding to Support Seniors and Senior Caregivers 2Health News:Home Care Assistance – Halton/Peel Region Weighs in on Alberta Communities Receiving Funding to Support Seniors and Senior Caregivers 3Health News:Famous Supplier Stwd.co.uk Announces Its New Selection of Evening Dresses for Women 2Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 2Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 3Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 2Health News:Mahendra Trivedi to Host an Online Workshop ‘Consciousness is Power’ 3
... students and faculty of Indian origin add to the rich ... some 430 km from here, where a gunman went on ... professor of Indian origin. ,Founded in 1872, the ... formally called, has more than 25,000 students from as many ...
... footage on television could intensify stress and trauma, according to// ... terrorist attacks on Sep 11, 2001 in the US, sleep ... Andover, Massachusetts, US, began teaching a class in which students ... remembered them. ,On the day after the ...
... According to Irish researchers, a smoking ban which began March ... a drastic cut //in air pollution, the health of bar ... the researchers gave an 83 percent reduction in air pollution ... addition, the report, which was published in the American Journal ...
... known as otitis media with effusion, which consists// of fluid ... ear infection, according to a report in the April issue ... JAMA/Archives journals. ,Otitis media with effusion, a ... space, but without earache, fever or other symptoms, has become ...
... causal organisms of hitherto common diseases// into ‘superbugs’. This, ... , One such example is the recent announcement by ... has now become resistant to the antibiotic fluoroquinolones. The ... creating worry lines on many a health expert. ...
... daily calcium intake is an effective way of identifying ... of osteoporosis, according to a research.// ,Researchers ... looked at a cross-section of 372 men with prostate ... and 28 per cent had undergone a radical prostatectomy. ...
Cached Medicine News:Health News:Indians Add to Rich Diversity of Virginia Tech 2Health News:Disturbing TV Scenes may Intensify Stress 2Health News:Ireland’s Smoke Ban Seems To Do The Tric 2Health News:Obesity may Be Linked to Middle Ear Effusions in Children 2Health News:Measuring Calcium Intake Help to Identify Osteoporosis in Prostate Cancer Patient 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: